SAVIMS

SAVIMS logo white
Menu

Vaccine effectiveness

COVID-19, Covid-19 vaccines, Other scientific evidence, Resource Type, Vaccine effectiveness, Vaccines, Viral illnesses

Israel’s Covid Crisis: A Closer Look

| | COVID-19, Covid-19 vaccines, Other scientific evidence, Resource Type, Vaccine effectiveness, Vaccines, Viral illnesses

Reference: Johnson, L. D. (2021, September 5). Israel now has more covid infections per capita than any country in the world. The Truth is Where? https://thetruthiswhere.wordpress.com/2021/09/05/israel-now-has-more-covid-infections-per-capita-than-any-country-in-the-world/ Summary: In September 2021, Israel experienced the highest per capita Covid-19 infection rates globally, despite an aggressive vaccination campaign. Initially lauded for vaccinating over 40% of its population, Israel […]

COVID-19, Covid-19 vaccines, Other scientific evidence, Resource Type, Vaccine effectiveness, Vaccine safety & adverse events, Vaccines, Viral illnesses

Evaluating COVID Vaccine Safety: A Critical Analysis

| | COVID-19, Covid-19 vaccines, Other scientific evidence, Resource Type, Vaccine effectiveness, Vaccine safety & adverse events, Vaccines, Viral illnesses

Reference: Kirsch, S. (2021). All you need to know about COVID vaccine safety. COVID-19 Early Treatment Fund. Retrieved from [source link] Summary: In “All you need to know about COVID vaccine safety,” Steve Kirsch argues that the COVID-19 vaccines may be causing more harm than good. He estimates over 150,000 excess deaths attributed to the

COVID-19, Covid-19 vaccines, Peer-reviewed evidence, Resource Type, Vaccine effectiveness, Vaccine safety & adverse events, Vaccines, Viral illnesses

Overview of the Main Anti-SARS-CoV-2 Vaccines

| | COVID-19, Covid-19 vaccines, Peer-reviewed evidence, Resource Type, Vaccine effectiveness, Vaccine safety & adverse events, Vaccines, Viral illnesses

Reference: Mascellino, M. T., Di Timoteo, F., De Angelis, M., & Oliva, A. (2021). Overview of the main anti-SARS-CoV-2 vaccines: Mechanism of action, efficacy and safety. Infection and Drug Resistance, 14, 3459–3476. https://doi.org/10.2147/IDR.S315727 Summary: The article reviews the principal vaccines developed against SARS-CoV-2 during the Covid-19 pandemic, detailing their mechanisms of action, efficacy, safety, and

COVID-19, Covid-19 vaccines, Peer-reviewed evidence, Resource Type, Vaccine effectiveness, Vaccine risk benefit analysis, Vaccine safety & adverse events, Vaccines, Viral illnesses

US COVID-19 Vaccines: A Critical Analysis of Health Impact

| | COVID-19, Covid-19 vaccines, Peer-reviewed evidence, Resource Type, Vaccine effectiveness, Vaccine risk benefit analysis, Vaccine safety & adverse events, Vaccines, Viral illnesses

Reference: Classen, B. (2021). US COVID-19 vaccines proven to cause more harm than good based on pivotal clinical trial data analysed using the proper scientific endpoint, “all cause severe morbidity”. Trends in Internal Medicine, 1(1), 1-6. Summary: The article by J. Bart Classen critiques the three COVID-19 vaccines approved in the US, asserting that they

COVID-19, Covid-19 vaccines, Other scientific evidence, Resource Type, Vaccine effectiveness, Vaccines, Viral illnesses

Comparing SARS-CoV-2 Natural Immunity to Vaccine-Induced Immunity

| | COVID-19, Covid-19 vaccines, Other scientific evidence, Resource Type, Vaccine effectiveness, Vaccines, Viral illnesses

Reference: Gazit, S., Shlezinger, R., Perez, G., Lotan, R., Peretz, A., Ben-Tov, A., Cohen, D., Muhsen, K., Chodick, G., & Patalon, T. (2021). Comparing SARS-CoV-2 natural immunity to vaccine-induced immunity: reinfections versus breakthrough infections. medRxiv. https://doi.org/10.1101/2021.08.24.21262415 Summary: This study compares the long-term protection provided by natural immunity from previous SARS-CoV-2 infection to that from the

COVID-19, Covid-19 vaccines, Other scientific evidence, Resource Type, Vaccine effectiveness, Vaccines, Viral illnesses

Kinetics of Antibody Decay After BNT162b2 Vaccination vs. SARS-CoV-2 Infection

| | COVID-19, Covid-19 vaccines, Other scientific evidence, Resource Type, Vaccine effectiveness, Vaccines, Viral illnesses

Reference: Israel, A., Shenhar, Y., Green, I., Merzon, E., Golan-Cohen, A., Schäffer, A. A., Ruppin, E., Magen, E., & Vinker, S. (2021). Elapsed time since BNT162b2 vaccine and risk of SARS-CoV-2 infection in a large cohort. medRxiv. https://doi.org/10.1101/2021.08.03.21261496 Summary: This study investigates the decay of SARS-CoV-2 IgG antibodies in individuals vaccinated with two doses of

COVID-19, Covid-19 vaccines, Peer-reviewed evidence, Resource Type, Vaccine effectiveness, Vaccines, Viral illnesses

Reduced Risk of Reinfection with SARS-CoV-2 After COVID-19 Vaccination

| | COVID-19, Covid-19 vaccines, Peer-reviewed evidence, Resource Type, Vaccine effectiveness, Vaccines, Viral illnesses

Reference: Cavanaugh, A. M., Spicer, K. B., Thoroughman, D., Glick, C., & Winter, K. (2021). Reduced risk of reinfection with SARS-CoV-2 after COVID-19 vaccination—Kentucky, May–June 2021. Morbidity and Mortality Weekly Report, 70(32), 1081-1083. https://www.cdc.gov/mmwr/volumes/70/wr/pdfs/mm7032e1-H.pdf Summary: A study conducted in Kentucky during May-June 2021 assessed the impact of COVID-19 vaccination on reinfection rates among individuals previously

COVID-19, Covid-19 vaccines, Other scientific evidence, Resource Type, Vaccine effectiveness, Vaccines, Viral illnesses

Reduced Reinfection Risk with Vaccination in Previously Infected Individuals

| | COVID-19, Covid-19 vaccines, Other scientific evidence, Resource Type, Vaccine effectiveness, Vaccines, Viral illnesses

Reference: Cavanaugh, A. M., Spicer, K. B., Thoroughman, D., Glick, C., & Winter, K. (2021). Reduced risk of reinfection with SARS-CoV-2 after COVID-19 vaccination – Kentucky, May–June 2021. Morbidity and Mortality Weekly Report, 70(32), 1081-1083. https://www.cdc.gov/mmwr/volumes/70/wr/pdfs/mm7032e1-H.pdf Summary: A study conducted in Kentucky investigated the impact of COVID-19 vaccination on reinfection rates among individuals previously infected

COVID-19, Ethics, Other scientific evidence, Reference Library, Resource Type, Vaccine effectiveness, Vaccine safety & adverse events, Vaccines, Viral illnesses

Rising Hospitalisations Among Vaccinated Individuals in Israel

| | COVID-19, Ethics, Other scientific evidence, Reference Library, Resource Type, Vaccine effectiveness, Vaccine safety & adverse events, Vaccines, Viral illnesses

Reference: Johnson, L. D. (2021, August 11). 95% of severe patients in Israeli hospitals are vaccinated, warns doctor. Natural News. https://www.naturalnews.com/2021-08-11-95-severe-patients-israeli-hospitals-are-vaccinated.html Summary: Dr. Kobi Haviv reports a troubling trend in Israel, where 95% of severe COVID-19 patients in hospitals are vaccinated. Despite over 78% vaccination coverage, Israel has experienced a rise in serious cases. The

COVID-19, Covid-19 vaccines, Epidemiological surveillance, Other scientific evidence, Resource Type, Statistical evidence, Vaccine effectiveness, Vaccines, Viral illnesses

Shedding of Infectious SARS-CoV-2 Despite Vaccination

| | COVID-19, Covid-19 vaccines, Epidemiological surveillance, Other scientific evidence, Resource Type, Statistical evidence, Vaccine effectiveness, Vaccines, Viral illnesses

Reference: Riemersma, K. K., Haddock, L. A. III, Wilson, N. A., Minor, N., Eickhoff, J., Grogan, B. E., Kita-Yarbro, A., Halfmann, P. J., Segaloff, H. E., Kocharian, A., Florek, K. R., Westergaard, R., Bateman, A., Jeppson, G. E., Kawaoka, Y., O’Connor, D. H., Friedrich, T. C., & Grande, K. M. (2022). Shedding of infectious SARS-CoV-2

Scroll to Top